Search

agbiopro
- May 18, 2019
- 0 min read

Vertex pays Kymera $70M upfront to discover protein degradation drugs

Recent Posts

ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing

GentiBio Launches with $20 Million Seed Funding from Novartis and Others

Kymera Therapeutics Unveils IPO Pitch for Protein Degradation